According to GlobalData’s medical device pipeline database, 152 Biopsy Devices devices are in various stages of development globally. GlobalData’s report Biopsy Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 67 are in active development, while the remaining 86 are in an inactive stage of development. There are 34 products in the early stages of development, and the remaining 33 are in the late stages of development.
Biopsy entails the removal of some tissue from the body for the purpose of diagnosis or for its examination under a microscope. A Biopsy Device is an instrument that aids in the removal of tissue samples from the body. Biopsy Guns, Vacuum-Assisted Needle Devices, Biopsy Forceps, Biopsy Punches and Biopsy Needles are covered under this category. One unit refers to one type of Biopsy Device.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Biopsy Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Biopsy Devices devices. Overall, most of these Biopsy Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Biopsy Devices include TransMed7, Triopsy Medical, Johns Hopkins University, SpectraScience, Control Medical Technology, University of Minnesota, NeoDynamics, Arch Medical Devices, Innovex Medical and University of Michigan.
For a complete picture of the developmental pipeline for Biopsy Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
